Condition: Cancer · Tyrosine Kinase Mutation · Breast Cancer · Sponsor: University of Alberta
People with advanced chronic cancers are now living for many years as a result of new targeted anti-cancer treatments. Many of these treatments are quite new and people may take them for months, even years, as long as the treatments are helping. The purpose of this study is to help understand how to best support people receiving these treatments.
This description comes directly from the study's public registry record.
Edith Pituskin, PhD · 7804328221 · pituskin@ualberta.ca
Meredith Porter Hogg, MN · lngeviti@ualberta.ca
Always discuss trial participation with your own doctor first.
| Edith Pituskin | Edmonton, Alberta, Canada | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05645510